Cell & Gene Advance Boston
Date: Location: Cost:
December 6, 2018 Harvard Medical School - Joseph B. Martin Conference Center
77 Avenue Louis Pasteur
Boston, MA 02115
(617) 262-9600
Location >

Starting at $1950

 

Dress Code:
Business Attire

Register

PAST AGENDA- September 25, 2017

2018 AGENDA COMING SOON!

Time Agenda
8:30-9:30 am

Registration and Networking Breakfast

9:30-9:45 am

Welcome and Opening Remarks
Louis Breton
CEO & co-Founder, Calimmune; Geoff Mackay, President & CEO, AvroBio

9:45-10:15 am

Gene Editing: Progress to the Clinic
Curt HerbertsCBO, Sangamo Therapeutics; Michael MaguireCEO, Avectas; Walter StrappsVP Discovery, Intellia Therapeutics 
Moderator: Michael DombeckVP, Business Development, Precision Biosciences

10:15-10:45 am

Next Generation RNA Technologies
Jeff Galvin, CEO, American Gene Technologies; Joseph Payne, Founder, President & CEO, Arcturus Therapeutics
Moderator: Edward Kaye, CEO, Stoke Therapeutics

10:45-11:15 am

Networking Break

11:15-11:45 am

Manufacturing and Commercialization: Strategies for Success
Geoff MacKay, President & CEO, AvroBio; James McLaughlin, President & CEO, Gemini Therapeutics; 
Alexander White, Head Agility & Rare Disease Commercialization, Roche
Moderator: Mark Shearman, CSO, AGTC

11:45-1:00 pm

Networking Lunch

1:00-1:30 pm

Moving Beyond Rare Diseases: What are the Challenges?
PJ Brooks, Program Director Office of Rare Diseases Research & Division of Clinical Innovation, NIH; Anne Marie Finley, President, Biotech Policy Group; Jeff Galvin, CEO, American Gene Technologies
Moderator: William AndrewsCMO, Acer Therapeutics


1:30-2:00 pm

Genetic Approaches to Hemophilia
Curt Herberts, CBO, Sangamo Therapeutics; Edward KayeCEO, Stoke Therapeutics
Moderator: Charles Richard IIIVP & Global Head Business Development, Gene Therapy Rare Diseases, Pfizer


 

2:00-2:30 pm

Academia, Industry, & Venture Partnerships: The New Wave
Anne Marie Finley, President, Biotech Policy Group; James McLaughlin, President & CEO, Gemini Therapeutics; Jack Reich, CEO & Co-Founder, Renova Therapeutics; Gregory Robinson, Chief Scientific Officer, Nightstar Therapeutics
Moderator: Nora Yang, Director, Portfolio Management & Strategic Operations, NIH

2:30-3:00 pm

Moderated Keynote
Pam Gavin
, COO, NORD
Moderator: Louis Breton, CEO & Co-Founder, Calimmune

3:00-3:30 pm

Networking Break

3:30-4:00 pm

Regulatory Strategies for Gene Therapy Products
John Maslowski, President & CEO, Fibrocell Science; Jennifer Spinella, EVP, Regulatory Affairs & Quality Assurance, Renova Therapeutics
Moderator: Jack Reich, CEO & Co-Founder, Renova Therapeutics

4:00-4:30 pm

Defining the Value of Genetic Therapies
Louis Breton
, CEO & Co-Founder, Calimmune; Francois Lebel, EVP of R&D, CMO, ZIOPHARM Oncology
Moderator: John Maslowski, President & CEO, Fibrocell Science

4:30-5:30 pm

Cocktails and Hors d'oeuvres

Supporting Sponsors: (see all sponsors)

<